Logo image of CBRE

CBRE GROUP INC - A (CBRE) Stock Fundamental Analysis

NYSE:CBRE - New York Stock Exchange, Inc. - US12504L1098 - Common Stock - Currency: USD

121.21  -7.11 (-5.54%)

Fundamental Rating

5

Taking everything into account, CBRE scores 5 out of 10 in our fundamental rating. CBRE was compared to 65 industry peers in the Real Estate Management & Development industry. Both the profitability and the financial health of CBRE get a neutral evaluation. Nothing too spectacular is happening here. CBRE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CBRE was profitable.
In the past year CBRE had a positive cash flow from operations.
CBRE had positive earnings in each of the past 5 years.
In the past 5 years CBRE always reported a positive cash flow from operatings.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

CBRE has a better Return On Assets (3.81%) than 90.77% of its industry peers.
CBRE has a better Return On Equity (12.13%) than 95.38% of its industry peers.
With an excellent Return On Invested Capital value of 7.14%, CBRE belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CBRE is in line with the industry average of 5.55%.
Industry RankSector Rank
ROA 3.81%
ROE 12.13%
ROIC 7.14%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CBRE's Profit Margin of 2.74% is fine compared to the rest of the industry. CBRE outperforms 70.77% of its industry peers.
CBRE's Profit Margin has declined in the last couple of years.
CBRE's Operating Margin of 4.29% is fine compared to the rest of the industry. CBRE outperforms 69.23% of its industry peers.
In the last couple of years the Operating Margin of CBRE has declined.
With a Gross Margin value of 19.59%, CBRE perfoms like the industry average, outperforming 41.54% of the companies in the same industry.
In the last couple of years the Gross Margin of CBRE has declined.
Industry RankSector Rank
OM 4.29%
PM (TTM) 2.74%
GM 19.59%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CBRE is destroying value.
CBRE has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CBRE has been reduced compared to 5 years ago.
CBRE has a worse debt/assets ratio than last year.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 3.36 indicates that CBRE is not in any danger for bankruptcy at the moment.
The Altman-Z score of CBRE (3.36) is better than 78.46% of its industry peers.
CBRE has a debt to FCF ratio of 5.05. This is a neutral value as CBRE would need 5.05 years to pay back of all of its debts.
The Debt to FCF ratio of CBRE (5.05) is better than 80.00% of its industry peers.
CBRE has a Debt/Equity ratio of 0.74. This is a neutral value indicating CBRE is somewhat dependend on debt financing.
CBRE's Debt to Equity ratio of 0.74 is in line compared to the rest of the industry. CBRE outperforms 44.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 5.05
Altman-Z 3.36
ROIC/WACC0.79
WACC9.02%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

CBRE has a Current Ratio of 1.00. This is a bad value and indicates that CBRE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.00, CBRE is doing worse than 69.23% of the companies in the same industry.
CBRE has a Quick Ratio of 1.00. This is a bad value and indicates that CBRE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 1.00, CBRE is not doing good in the industry: 63.08% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

6

3. Growth

3.1 Past

CBRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.27%, which is quite impressive.
The Earnings Per Share has been growing slightly by 6.61% on average over the past years.
The Revenue has grown by 13.14% in the past year. This is quite good.
The Revenue has been growing by 8.40% on average over the past years. This is quite good.
EPS 1Y (TTM)40.27%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%10.26%
Revenue 1Y (TTM)13.14%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%12.29%

3.2 Future

CBRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.61% yearly.
Based on estimates for the next years, CBRE will show a small growth in Revenue. The Revenue will grow by 7.92% on average per year.
EPS Next Y18.59%
EPS Next 2Y18.55%
EPS Next 3Y17.58%
EPS Next 5Y16.61%
Revenue Next Year12.48%
Revenue Next 2Y10.44%
Revenue Next 3Y8.25%
Revenue Next 5Y7.92%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

CBRE is valuated rather expensively with a Price/Earnings ratio of 23.35.
Based on the Price/Earnings ratio, CBRE is valued a bit cheaper than the industry average as 76.92% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.60, CBRE is valued at the same level.
The Price/Forward Earnings ratio is 16.88, which indicates a correct valuation of CBRE.
Based on the Price/Forward Earnings ratio, CBRE is valued cheaply inside the industry as 81.54% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.43. CBRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 23.35
Fwd PE 16.88
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 72.31% of the companies listed in the same industry.
CBRE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CBRE is cheaper than 73.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.75
EV/EBITDA 18.02
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CBRE may justify a higher PE ratio.
CBRE's earnings are expected to grow with 17.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.26
PEG (5Y)3.53
EPS Next 2Y18.55%
EPS Next 3Y17.58%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CBRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CBRE GROUP INC - A

NYSE:CBRE (5/21/2025, 3:34:07 PM)

121.21

-7.11 (-5.54%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)04-24 2025-04-24/bmo
Earnings (Next)07-23 2025-07-23/bmo
Inst Owners99.1%
Inst Owner Change0.67%
Ins Owners0.57%
Ins Owner Change7.52%
Market Cap36.13B
Analysts81.05
Price Target147.59 (21.76%)
Short Float %1.47%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.34%
Min EPS beat(2)2.25%
Max EPS beat(2)10.42%
EPS beat(4)4
Avg EPS beat(4)7.16%
Min EPS beat(4)2.25%
Max EPS beat(4)10.89%
EPS beat(8)8
Avg EPS beat(8)8.24%
EPS beat(12)11
Avg EPS beat(12)8.13%
EPS beat(16)14
Avg EPS beat(16)13.22%
Revenue beat(2)0
Avg Revenue beat(2)-1.39%
Min Revenue beat(2)-1.96%
Max Revenue beat(2)-0.83%
Revenue beat(4)1
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-1.96%
Max Revenue beat(4)0.71%
Revenue beat(8)4
Avg Revenue beat(8)0.79%
Revenue beat(12)6
Avg Revenue beat(12)0.26%
Revenue beat(16)9
Avg Revenue beat(16)0.34%
PT rev (1m)-7.89%
PT rev (3m)-6.22%
EPS NQ rev (1m)-5.14%
EPS NQ rev (3m)-7.88%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-1.83%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)1.25%
Revenue NY rev (1m)0.59%
Revenue NY rev (3m)1.5%
Valuation
Industry RankSector Rank
PE 23.35
Fwd PE 16.88
P/S 0.98
P/FCF 26.75
P/OCF 21.85
P/B 4.36
P/tB N/A
EV/EBITDA 18.02
EPS(TTM)5.19
EY4.28%
EPS(NY)7.18
Fwd EY5.93%
FCF(TTM)4.53
FCFY3.74%
OCF(TTM)5.55
OCFY4.58%
SpS123.25
BVpS27.78
TBVpS-1.59
PEG (NY)1.26
PEG (5Y)3.53
Profitability
Industry RankSector Rank
ROA 3.81%
ROE 12.13%
ROCE 10.18%
ROIC 7.14%
ROICexc 7.73%
ROICexgc 16.05%
OM 4.29%
PM (TTM) 2.74%
GM 19.59%
FCFM 3.68%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
ROICexc(3y)8.16%
ROICexc(5y)8.57%
ROICexgc(3y)18.67%
ROICexgc(5y)19.47%
ROCE(3y)9.51%
ROCE(5y)9.85%
ROICexcg growth 3Y-10.49%
ROICexcg growth 5Y-5.25%
ROICexc growth 3Y-6.39%
ROICexc growth 5Y-5.52%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
F-Score6
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 5.05
Debt/EBITDA 2.69
Cap/Depr 43.72%
Cap/Sales 0.82%
Interest Coverage 3.96
Cash Conversion 72.84%
Profit Quality 134.43%
Current Ratio 1
Quick Ratio 1
Altman-Z 3.36
F-Score6
WACC9.02%
ROIC/WACC0.79
Cap/Depr(3y)45.67%
Cap/Depr(5y)46.01%
Cap/Sales(3y)0.89%
Cap/Sales(5y)0.91%
Profit Quality(3y)86.59%
Profit Quality(5y)117.01%
High Growth Momentum
Growth
EPS 1Y (TTM)40.27%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%10.26%
EPS Next Y18.59%
EPS Next 2Y18.55%
EPS Next 3Y17.58%
EPS Next 5Y16.61%
Revenue 1Y (TTM)13.14%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%12.29%
Revenue Next Year12.48%
Revenue Next 2Y10.44%
Revenue Next 3Y8.25%
Revenue Next 5Y7.92%
EBIT growth 1Y23.47%
EBIT growth 3Y-0.86%
EBIT growth 5Y2.79%
EBIT Next Year55.62%
EBIT Next 3Y22.12%
EBIT Next 5Y18.39%
FCF growth 1Y35.17%
FCF growth 3Y-13.36%
FCF growth 5Y8.54%
OCF growth 1Y29.44%
OCF growth 3Y-10.27%
OCF growth 5Y6.9%